허가사항 범위 내에서 아래와 같은 기준으로 투여 시 요양급여를 인정하며, 동 인정기준 이외에는 약값 전액을 환자가 부담토록 함.(내용액제 포함)
- 아 래 -
○ 역류성 식도염의 자각증상 개선
■ 고시 신설 고시번호(시행일자)
고시 제2022-268호(2022.12.1.)
■ 고시 신설 사유
○’22년 급여적정성 재평가 결과에 따라, 급여기준을 신설함
■ 관련문헌 등
· 비출혈 소화성궤양 치료의 가이드라인 (2009)
· Hazzard’s Geriatric Medicine and Gerotology, 7e (2017)
· Netter’s Gastroenterology, 3e (2019)
· Dysphagia: Diagnosis and Treat ment, 2e (2019)
· Clinical Pharmacology During Pregnancy, 2e (2021)
· 위식도역류질환 임상진료지침 개정안 (2012)
· 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease Alginate-based Therapy (2020)
· ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (2022)
· Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021 (2021)
· Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus (2016)
· Gastro-oesophageal reflux in children and young people (2016)
· Effect of Sodium Alginate on Gastrointestinal Symptoms after Esophagogastroduodenoscopy with Biopsy: Randomized Controlled Trial.(Nam et al.,2022)
· The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.(Kim et al.,2019)
· Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.(Manabe et al.,2012)
· Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.(Buono et al.,2004)